The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
Katarzyna Kapica-TopczewskaJoanna TarasiukFrancois CollinWaldemar BrolaMonika ChorążyAgata CzarnowskaMirosław KwaśniewskiHalina Bartosik-PsujekMonika Adamczyk-SowaJan KochanowiczAlina KułakowskaPublished in: PloS one (2019)
IFNβ compared to GA and NAT compared to FTY more effectively reduced disease activity in a Polish population of RRMS patients.
Keyphrases
- disease activity
- multiple sclerosis
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- rheumatoid arthritis patients
- dendritic cells
- ejection fraction
- randomized controlled trial
- newly diagnosed
- chronic kidney disease
- prognostic factors
- pet ct
- peritoneal dialysis
- systematic review
- juvenile idiopathic arthritis
- immune response